BPG is committed to discovery and dissemination of knowledge
Randomized Controlled Trial
©Author(s) (or their employer(s)) 2026.
World J Clin Pediatr. Mar 9, 2026; 15(1): 111304
Published online Mar 9, 2026. doi: 10.5409/wjcp.v15.i1.111304
Table 1 Baseline characteristics of study participants, n (%)/median (25th-75th percentiles)/mean ± SD
Characteristics
BES (n = 30)
NS (n = 30)
P value
Age (years)10.77 ± 1.3610.63 ± 1.50.72
Female23 (76.7)21 (70)0.56
Anthropometric parameters
Weight (kg)19.2 ± 6.519.5 ± 6.40.84
Height (cm)131.2 ± 24.1130.9 ± 24.30.77
BMI (kg/m2)19.6 ± 3.419.4 ± 3.50.92
Socio-economic status (poor)6 (20)5 (16.7)0.63
Family history of diabetes3 (10)2 (6.7)0.44
Known case of diabetes10 (33.3)11 (36.7)0.59
Age (year) at onset of diabetes5 ± 25 ± 20.99
Previous history of DKA16 (53.3)17 (56.7)0.73
Precipitating event present15 (50)17 (56.7)0.42
Infection present9 (30)7 (23.3)0.39
Poor compliance17 (56.7)18 (60)0.65
Severity of DKA at presentation
Mild2 (3.3)2 (6.7)
Moderate7 (6.9)8 (3.3)0.39
Severe21 (70)20 (66.7)
Shock at presentation2 (6.7)1 (3.3)0.17
GCS at admission13 ± 213 ± 20.97
Blood glucose (mg/dL)452 (364-548)448 (354-542)0.48
Hb1Ac (%)9.8 (8.8-12)9.6 (8.6-11.5)0.76
Laboratory parameters
Blood pH7.01 (6.9-7.18)7.02 (6.9-7.2)0.59
PCO220 (15-23)19 (16-22)0.71
HCO3 (mmol/L)7.2 (5.6-10.1)7 (5.5-9.5)0.81
Lactate (mmol/L)2 (1-3)2 (1-3)0.93
Anion gap (mmol/L)16 (14-20)17 (14-19)0.77
Serum osmolality (mmol/kg)296 (291-310)298 (293-310)0.56
Sodium (corrected) (meq/L)136 (132-139)138 (134-141)0.84
Potassium (meq/L)3.9 (3.4-4.2)3.7 (3.4-4.1)0.51
Phosphate (mg/dL)3.4 (3.1-4)3.8 (3.2-4)0.48
Chloride (meq/L)108 (104-112)106 (101-110)0.59
Renal function test
Urea (mg/dL)35 (28-61)32 (25-54)0.23
Creatinine (mg/dL)0.7 (0.4-1.2)0.7 (0.5-1.3)0.65
Table 2 Treatment details of both the groups, n (%)/median (25th-75th percentiles)
Characteristics
BES (n = 30)
NS (n = 30)
P value
Estimated fluid deficit (%)7.5 (6.5-8.5)7.5 (6.5-8.5)0.91
Total fluid administered (L)1.12 (0.9-1.79)1.38 (1-1.81)0.29
Study fluid administered (L)0.4 (0.3-0.62)0.44 (0.3-0.58)0.36
Duration of study fluid (hour)5 (3-6)5 (3, 6)0.77
Need of insulin hike9 (30)7 (23.3)0.39
Insulin dose (maximum), unit/kg0.05 (0.05-0.05)0.05 (0.05-1)0.21
Urine output (mL/kg/hour) till end-point2.6 (2-4)2.5 (2-4)0.63
Total fluid balance (mL/kg)34 (14-52)36 (16-55)0.54
Table 3 Outcomes (primary and secondary) in both the groups, n (%)/median (25th-75th percentiles)
Characteristics
BES (n = 30)
NS (n = 30)
P value
Primary outcome
Time taken for resolution of acidosis (hour)12 (8-18)16 (10-22)0.16
Secondary outcomes
Duration of hospital stay (day)4 (3-5)5 (3-6)0.23
Complications
Acute kidney injury10 (0)3 (10)0.07
Cerebral edema0 (0)1 (3.3)0.21
Required mechanical ventilation1 (3.3)1 (3.3)0.86
Required inotropes1 (3.3)0 (0)0.21
Hypernatremia1 (3.3)1 (3.3)0.86
Hyponatremia5 (16.7)4 (13.3)0.42
Hyperchloremia1 (3.3)3 (10)0.09
Hypokalemia3 (10)5 (16.7)0.08